MicroRNAs: Key regulators of endothelial progenitor cell functions

Clinica Chimica Acta

Volumn 448, Issue , 2015, Pages 65-73

  Qu, Kai ^a   Wang, Zuo ^a   Lin, Xiao long ^b   Zhang, Kai ^c   He, Xing lan ^a   Zhang, Hai ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Department of Pathology The Third People's Hospital of Huizhou   (China)

^c THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Angiogenesis; Cardiovascular diseases; Endothelial progenitor cells; MicroRNA

Indexed keywords

MICRORNA;

ANIMAL; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; HUMAN; METABOLISM;

ANIMALS; ENDOTHELIAL PROGENITOR CELLS; HUMANS; MICRORNAS;

EID: 84934280174     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.06.017     Document Type: Review

References (81)

1. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
3. Centola M., Capogrossi M.C. Role of G-CSF and GM-CSF therapy in patients with acute myocardial infarction and critical limb ischemia. G Ital Cardiol (Rome) 2014, 15:465-474.
4. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
5. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10344-10349.
6. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
7. Bhattacharya V., McSweeney P.A., Shi Q., et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000, 95:581-585.
8. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 2002, 8:403-409.
9. Sen S., McDonald S.P., Coates P.T., Bonder C.S. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin. Sci. (Lond.) 2011, 120:263-283.
10. Kim C., Schneider G., Abdel-Latif A., et al. Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells-implications for tissue regeneration. Stem Cells 2013, 31:500-510.
11. Kong D., Melo L.G., Gnecchi M., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004, 110:2039-2046.
12. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
13. Schroder K., Kohnen A., Aicher A., et al. NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ. Res. 2009, 105:537-544.
14. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
15. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N. Y. Acad. Sci. 2001, 938:221-229. [229-230].
16. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
17. Hur J., Yoon C.H., Kim H.S., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
18. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
19. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
20. Zeng Y., Yi R., Cullen B.R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9779-9784.
21. Tang G., Reinhart B.J., Bartel D.P., Zamore P.D. A biochemical framework for RNA silencing in plants. Genes Dev. 2003, 17:49-63.
22. Rhoades M.W., Reinhart B.J., Lim L.P., Burge C.B., Bartel B., Bartel D.P. Prediction of plant microRNA targets. Cell 2002, 110:513-520.
23. Olsen P.H., Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 1999, 216:671-680.
24. Minami Y., Satoh M., Maesawa C., et al. Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur. J. Clin. Investig. 2009, 39:359-367.
25. Chang T.Y., Huang T.S., Wang H.W., et al. miRNome traits analysis on endothelial lineage cells discloses biomarker potential circulating microRNAs which affect progenitor activities. BMC Genomics 2014, 15:802.
26. Zhang Q., Kandic I., Kutryk M.J. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem. Biophys. Res. Commun. 2011, 405:42-46.
27. Zhang X., Mao H., Chen J.Y., et al. Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf/MEK/ERK pathway. Biochem. Biophys. Res. Commun. 2013, 431:404-408.
28. Meng S., Cao J., Zhang X., et al. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One 2013, 8:e68611.
29. Fish J.E., Santoro M.M., Morton S.U., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15:272-284.
30. Meng S., Cao J.T., Zhang B., Zhou Q., Shen C.X., Wang C.Q. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J. Mol. Cell. Cardiol. 2012, 53:64-72.
31. Yan T., Liu Y., Cui K., Hu B., Wang F., Zou L. MicroRNA-126 regulates EPCs function: implications for a role of miR-126 in preeclampsia. J. Cell. Biochem. 2013, 114:2148-2159.
32. Goerke S.M., Kiefer L.S., Stark G.B., Simunovic F., Finkenzeller G. miR-126 modulates angiogenic growth parameters of peripheral blood endothelial progenitor cells. Biol. Chem. 2015, 396:245-252.
33. Kim Y.J., Hwang S.H., Lee S.Y., et al. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev. 2012, 21:1749-1760.
34. Yang D.G., Liu L., Zhou S.H. MicroRNA alterations in senescent endothelial progenitor cells induced by remnant-like lipoproteins. Chin. Med. J. 2012, 125:3479-3484.
35. Zhu S., Deng S., Ma Q., et al. MicroRNA-10A* and microRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2. Circ. Res. 2013, 112:152-164.
36. Tabuchi T., Satoh M., Itoh T., Nakamura M. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin. Sci. (Lond.) 2012, 123:161-171.
37. Zheng Y., Xu Z. MicroRNA-22 induces endothelial progenitor cell senescence by targeting AKT3. Cell. Physiol. Biochem. 2014, 34:1547-1555.
38. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
39. van Solingen C., de Boer H.C., Bijkerk R., et al. MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemia. Cardiovasc. Res. 2011, 92:449-455.
40. Rolland-Turner M., Goretti E., Bousquenaud M., et al. Adenosine stimulates the migration of human endothelial progenitor cells. Role of CXCR4 and microRNA-150. PLoS One 2013, 8:e54135.
41. Tano N., Kim H.W., Ashraf M. MicroRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS One 2011, 6:e23114.
42. Wang W., Li C., Li W., et al. MiR-150 enhances the motility of EPCs in vitro and promotes EPCs homing and thrombus resolving in vivo. Thromb. Res. 2014, 133:590-598.
43. Iwaguro H., Yamaguchi J., Kalka C., et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002, 105:732-738.
44. Wang H.W., Lo H.H., Chiu Y.L., et al. Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease. PLoS One 2014, 9:e98070.
45. Jin Y., Yang C.J., Xu X., Cao J.N., Feng Q.T., Yang J. MiR-214 regulates the pathogenesis of patients with coronary artery disease by targeting VEGF. Mol. Cell. Biochem. 2015, 402:111-122.
46. Meng S., Cao J., Wang L., et al. MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1beta. PLoS One 2012, 7:e40323.
47. Goretti E., Rolland-Turner M., Leonard F., Zhang L., Wagner D.R., Devaux Y. MicroRNA-16 affects key functions of human endothelial progenitor cells. J. Leukoc. Biol. 2013, 93:645-655.
48. Cheng B.B., Qu M.J., Wu L.L., et al. MicroRNA-34a targets Forkhead box j2 to modulate differentiation of endothelial progenitor cells in response to shear stress. J. Mol. Cell. Cardiol. 2014, 74:4-12.
49. Zhang J., Zhang Z., Zhang D.Y., Zhu J., Zhang T., Wang C. MicroRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway. PLoS One 2013, 8:e83294.
50. Obi S., Yamamoto K., Shimizu N., et al. Fluid shear stress induces arterial differentiation of endothelial progenitor cells. J. Appl. Physiol. 2009, 106(1985):203-211.
51. Obi S., Masuda H., Shizuno T., et al. Fluid shear stress induces differentiation of circulating phenotype endothelial progenitor cells. Am. J. Physiol. Cell Physiol. 2012, 303:C595-C606.
52. Moonen J.R., Krenning G., Brinker M.G., Koerts J.A., van Luyn M.J., Harmsen M.C. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc. Res. 2010, 86:506-515.
53. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997, 349:1436-1442.
54. Wang H.W., Huang T.S., Lo H.H., et al. Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2014, 34:857-869.
55. Zhao T., Li J., Chen A.F. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E110-E116.
56. Chiu S.C., Chiang E.P., Tsai S.Y., et al. Eicosapentaenoic acid induces neovasculogenesis in human endothelial progenitor cells by modulating c-kit protein and PI3-K/Akt/eNOS signaling pathways. J. Nutr. Biochem. 2014, 25:934-945.
57. Chiang E.P., Chiu S.C., Pai M.H., et al. Organosulfur garlic compounds induce neovasculogenesis in human endothelial progenitor cells through a modulation of microRNA 221 and the PI3-K/Akt signaling pathways. J. Agric. Food Chem. 2013, 61:4839-4849.
58. Liu G.T., Chen H.T., Tsou H.K., et al. CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells. Oncotarget 2014, 5:10718-10731.
59. Deregibus M.C., Cantaluppi V., Calogero R., et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110:2440-2448.
60. Cantaluppi V., Gatti S., Medica D., et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012, 82:412-427.
61. Cantaluppi V., Biancone L., Figliolini F., et al. Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant. 2012, 21:1305-1320.
62. Qiang L., Hong L., Ningfu W., Huaihong C., Jing W. Expression of miR-126 and miR-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients. Int. J. Cardiol. 2013, 168:2082-2088.
63. Xu Q., Meng S., Liu B., et al. MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3. Clin. Exp. Pharmacol. Physiol. 2014, 41:351-357.
64. Chung E., Kondo M. Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development. Immunol. Res. 2011, 49:248-268.
65. Manser E., Leung T., Salihuddin H., Zhao Z.S., Lim L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994, 367:40-46.
66. Bagheri-Yarmand R., Vadlamudi R.K., Wang R.A., Mendelsohn J., Kumar R. Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis. J. Biol. Chem. 2000, 275:39451-39457.
67. Liu X., Cohen J.I. The role of PI3K/Akt in human herpesvirus infection: from the bench to the bedside. Virology 2015, 479-480C:568-577.
68. Huang Q., Sheibani N. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am. J. Physiol. Cell Physiol. 2008, 295:C1647-C1657.
69. Lennartsson J., Ronnstrand L. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol. Rev. 2012, 92:1619-1649.
70. Kim K.L., Meng Y., Kim J.Y., Baek E.J., Suh W. Direct and differential effects of stem cell factor on the neovascularization activity of endothelial progenitor cells. Cardiovasc. Res. 2011, 92:132-140.
71. Wang Y., Yan W., Lu X., et al. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avbeta3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur. J. Cell Biol. 2011, 90:642-648.
72. Ishizaki T., Tamiya T., Taniguchi K., et al. miR126 positively regulates mast cell proliferation and cytokine production through suppressing Spred1. Genes Cells 2011, 16:803-814.
73. Wakioka T., Sasaki A., Kato R., et al. Spred is a Sprouty-related suppressor of Ras signalling. Nature 2001, 412:647-651.
74. Ueki K., Fruman D.A., Yballe C.M., et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J. Biol. Chem. 2003, 278:48453-48466.
75. Shen L., Gao Y., Qian J., et al. The role of SDF-1alpha/Rac pathway in the regulation of endothelial progenitor cell polarity; homing and expression of Rac1, Rac2 during endothelial repair. Mol. Cell. Biochem. 2012, 365:1-7.
76. Zhao X., Qian D., Wu N., et al. The spleen recruits endothelial progenitor cell via SDF-1/CXCR4 axis in mice. J. Recept. Signal Transduct. Res. 2010, 30:246-254.
77. Grunewald M., Avraham I., Dor Y., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
78. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 2003, 9:677-684.
79. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 2004, 10:858-864.
80. Goldberg M.A., Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 1994, 269:4355-4359.
81. Hoenig M.R., Bianchi C., Sellke F.W. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Curr. Drug Targets 2008, 9:422-435.